Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.80
19.09.23
€44.85
19.09.24
-16.10%
20.09.24

HC Wainwright 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.20
18.09.23
€262.05
18.09.24
22.28%
19.09.24

Argus 
18.09.23 50%
buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€22.80
18.09.23
€42.12
18.09.24
40.35%
19.09.24

Truist Financial Co. 
18.09.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€168.00
18.09.23
€378.55
18.09.24
45.24%
19.09.24

HC Wainwright 
18.09.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.30
18.09.23
€201.11
18.09.24
-1.52%
19.09.24

Cantor Fitzgerald 
18.09.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.90
18.09.23
€70.28
18.09.24
-15.69%
19.09.24

Cantor Fitzgerald 
18.09.23 50%
sell
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€22.80
18.09.23
€20.61
18.09.24
40.35%
19.09.24

The Goldman Sachs Group, Inc. 
18.09.23 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.76
18.09.23
€38.46
18.09.24
168.84%
19.09.24

HC Wainwright 
18.09.23 50%
sell
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€7.40
17.09.24
-
17.09.25
-16.22%
18.09.24

Risky Investment
Wolf_of_WS 
17.09.24 50%
sell
Bayer AG ADR

Start price
Target price
Perf. (%)
€6.90
03.09.24
€7.00
03.09.25
-0.72%
18.09.24

High valuation
Low dividend yield expected
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Traumtanz 
03.09.24 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€3.44
17.08.24
€14.00
17.09.24
-20.19%
18.09.24

Undervalued
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
ROKOBA 
17.08.24 90%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
17.09.23
-
17.09.24
-
18.09.24

StockNews.com 
17.09.23 50%
sell
Arca Biopharma

Start price
Target price
Perf. (%)
€1.88
17.09.23
-
17.09.24
166.36%
18.09.24

StockNews.com 
17.09.23 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€4.74
17.09.24
-
17.09.25
61.39%
17.09.24

Very capable Management
Could be worthwhile Investment >10% per year
Little innovation
Warner 
17.09.24 0%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€6.60
03.09.24
-
03.09.25
-2.03%
17.09.24

daimler1 
03.09.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€5.95
16.08.24
-
16.09.24
5.71%
17.09.24

ShortPayable90 
16.08.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€29.50
16.08.24
-
16.09.24
-9.34%
17.09.24

LeverageRetail97 
16.08.24 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€11.58
16.08.24
-
16.09.24
1.93%
17.09.24

ExpenseSlip16 
16.08.24 50%
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€41.00
16.09.23
€80.00
16.09.24
-21.95%
17.09.24

WatchMen 
16.09.23 0%
sell
Durect Corp.

Start price
Target price
Perf. (%)
€0.37
16.09.23
-
16.09.24
-
17.09.24

StockNews.com 
16.09.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.61
01.09.24
-
01.09.25
6.48%
16.09.24

Could be worthwhile Investment >10% per year
quelbe60 
01.09.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.12
01.09.24
-
01.09.25
8.07%
16.09.24

Risky Investment
quelbe60 
01.09.24 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.20
01.09.24
-
01.09.25
0.64%
16.09.24

quelbe60 
01.09.24 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€26.15
15.08.24
-
15.09.24
2.70%
16.09.24

IndexUptrend79 
15.08.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.09
15.09.23
€28.10
15.09.24
76.82%
16.09.24

Mizuho 
15.09.23 50%